The Effect of Restrictive Fluid and Vasopressin During Surgery of Burn Patients

Burn Surgery Clinical Trial

Official title:
The Effect of Restrictive Fluid and Vasopressin During Surgery of Burn Patients: a Randomized Clinical Trial

Status Recruiting

Clinical Trial Summary

This is a randomized double-blinded study to investigate in which the groups are designated as the control group and the restrictive group to further evaluate significant differences in intraoperative blood loos during burn surgery.

Clinical Trial Description

This is a randomized double-blinded study to investigate the effect of fluid restriction and vasopressin on blood loss during surgery of the burn patients. The groups are designated as the control group and the restrictive group to further evaluate significant differences in intraoperative blood loss during the surgery. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03590873
Study type	Interventional
Source	Hangang Sacred Heart Hospital
Contact	Hee Yeong Kim, MD
Phone	82226395650
Email	kimhy@hallym.or.kr
Status	Recruiting
Phase	N/A
Start date	July 25, 2018
Completion date	June 4, 2019

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT00974597` - Comparison of AWBAT™-D and MEPILEX® AG for Treatment of Donor Sites in Burn Surgery	N/A
Recruiting	`NCT03884036` - Effect of Vitamin D in Burn Patients	N/A
Not yet recruiting	`NCT05241912` - Supernormal Oxygen Delivery for Patients With Severe Burns	Early Phase 1